[go: up one dir, main page]

NO20051187L - Depotformuleringer bestaende av aktive arylheterocykliske forbindelser i form av en suspensjon - Google Patents

Depotformuleringer bestaende av aktive arylheterocykliske forbindelser i form av en suspensjon

Info

Publication number
NO20051187L
NO20051187L NO20051187A NO20051187A NO20051187L NO 20051187 L NO20051187 L NO 20051187L NO 20051187 A NO20051187 A NO 20051187A NO 20051187 A NO20051187 A NO 20051187A NO 20051187 L NO20051187 L NO 20051187L
Authority
NO
Norway
Prior art keywords
depositional
suspension
active
formulations consisting
arylheterocyclic
Prior art date
Application number
NO20051187A
Other languages
English (en)
Norwegian (no)
Inventor
Jaymin Chandrakant Shah
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20051187L publication Critical patent/NO20051187L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20051187A 2002-10-25 2005-03-04 Depotformuleringer bestaende av aktive arylheterocykliske forbindelser i form av en suspensjon NO20051187L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42129502P 2002-10-25 2002-10-25
PCT/IB2003/004535 WO2004037224A1 (en) 2002-10-25 2003-10-13 Depot formulations of arylheterocyclic active agents in the form of a suspension

Publications (1)

Publication Number Publication Date
NO20051187L true NO20051187L (no) 2005-04-11

Family

ID=32176696

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051187A NO20051187L (no) 2002-10-25 2005-03-04 Depotformuleringer bestaende av aktive arylheterocykliske forbindelser i form av en suspensjon

Country Status (21)

Country Link
US (1) US20040146562A1 (es)
EP (1) EP1562546A1 (es)
JP (2) JP2006505579A (es)
KR (1) KR20050071611A (es)
CN (1) CN1703198A (es)
AR (1) AR041826A1 (es)
AU (1) AU2003267763A1 (es)
BR (1) BR0315663A (es)
CA (1) CA2498276A1 (es)
GT (1) GT200300227A (es)
MX (1) MXPA05004299A (es)
NL (1) NL1024616C (es)
NO (1) NO20051187L (es)
PA (1) PA8586301A1 (es)
PE (1) PE20040471A1 (es)
PL (1) PL375603A1 (es)
RU (1) RU2292207C2 (es)
TW (1) TW200418477A (es)
UY (1) UY28035A1 (es)
WO (1) WO2004037224A1 (es)
ZA (1) ZA200501979B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080113025A1 (en) * 1998-11-02 2008-05-15 Elan Pharma International Limited Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
UA79984C2 (en) * 2002-08-20 2007-08-10 Bristol Myers Squibb Co Preparation on the basis of aripiprazole complex and use thereof
CN101797221B (zh) 2002-12-13 2013-06-12 杜雷科特公司 包含高粘度液体载体材料的口服递药系统
JP2007522095A (ja) * 2003-05-16 2007-08-09 ファイザー・プロダクツ・インク ジプラシドンを用いた不安の治療
WO2006000913A1 (en) * 2004-06-23 2006-01-05 Pfizer Products Inc. Method for sterile filtration of viscous pharmaceutical compositions
DK2767292T3 (en) * 2004-09-17 2016-12-19 Durect Corp RENEWABLE local anesthetic COMPOSITION CONTAINING SAIB
EP1855651A4 (en) * 2005-03-03 2011-06-15 Elan Pharma Int Ltd NANOPARTICLE COMPOSITIONS OF HETEROCYCLIC AMID DERIVATIVES
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
CN100391458C (zh) * 2006-02-07 2008-06-04 上海医药工业研究院 齐拉西酮或其盐包合物制备方法
AU2007248949B2 (en) * 2006-05-09 2010-04-08 Astrazeneca Ab Parenteral formulation comprising proton pump inhibitor sterilized in its final container by ionizing radiation
EP2484347A1 (en) 2006-11-03 2012-08-08 Durect Corporation Transdermal delivery systems comprising bupivacaine
WO2009075782A1 (en) 2007-12-06 2009-06-18 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
TW201521769A (zh) 2013-03-15 2015-06-16 Durect Corp 具有流變改質劑以減少溶解變異性之組成物
MY205229A (en) 2016-07-06 2024-10-08 Durect Corp Oral dosage form with drug composition, barrier layer and drug layer
US11197850B2 (en) * 2017-02-23 2021-12-14 Shanghai Synergy Pharmaceutical Sciences Co., Ltd. Powder injection of the donepezil semi palmoxiric acid salt, composition containing same and preparation method therefor
CA3167217A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
CN116940358A (zh) 2021-01-12 2023-10-24 度勒科特公司 持续释放药物递送系统和有关的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989002265A1 (fr) * 1987-09-07 1989-03-23 Teijin Limited Emulsion grasse contenant un medicament, du type prepare immediatement avant l'utilisation, et procede de preparation d'une telle emulsion grasse contenant un medicament
GB9200247D0 (en) * 1992-01-07 1992-02-26 Erba Carlo Spa Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
JP3954115B2 (ja) * 1992-07-28 2007-08-08 アストラゼネカ・アクチエボラーグ 注射剤および注射剤キット
US5594141A (en) * 1994-11-23 1997-01-14 Neurogen Corporation Certain aminomethyl biphenyl, aminomethyl phenyl pyridine and aminomethyl phenyl pyrimidine derivatives; novel dopamine receptor subtype selective ligands
US6040295A (en) * 1995-01-13 2000-03-21 Genemedicine, Inc. Formulated nucleic acid compositions and methods of administering the same for gene therapy
UA57734C2 (uk) * 1996-05-07 2003-07-15 Пфайзер Інк. Комплекси включення арилгетероциклічних солей
ATE277641T1 (de) * 1996-05-07 2004-10-15 Pfizer Verfahren zur selektion eines salzes zur herstellung eines inklusionskomplexes
PT949905E (pt) * 1996-12-20 2001-12-28 Alza Corp Composicao de gel injectavel de efeito retardado e processo para a sua preparacao
HUP0003393A3 (en) * 1997-05-16 2001-03-28 Amgen Inc Thousand Oaks Ustained-release delayed gels
UA72189C2 (uk) * 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
EA003907B1 (ru) * 1999-05-27 2003-10-30 Пфайзер Продактс Инк. Композиция зипразидона в виде суспензии
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
WO2002074200A1 (en) * 2001-03-20 2002-09-26 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin
EP1269994A3 (en) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmaceutical compositions comprising drug and concentration-enhancing polymers
JP2005508625A (ja) * 2001-08-31 2005-04-07 ザ ロックフェラー ユニバーシティー 抗精神病薬の分類方法

Also Published As

Publication number Publication date
JP2006505579A (ja) 2006-02-16
JP2006219501A (ja) 2006-08-24
MXPA05004299A (es) 2005-08-03
PE20040471A1 (es) 2004-08-14
KR20050071611A (ko) 2005-07-07
NL1024616A1 (nl) 2004-04-27
ZA200501979B (en) 2006-04-26
PL375603A1 (en) 2005-12-12
CA2498276A1 (en) 2004-05-06
EP1562546A1 (en) 2005-08-17
AU2003267763A1 (en) 2004-05-13
TW200418477A (en) 2004-10-01
WO2004037224A1 (en) 2004-05-06
UY28035A1 (es) 2004-05-31
GT200300227A (es) 2004-06-23
BR0315663A (pt) 2005-08-30
CN1703198A (zh) 2005-11-30
NL1024616C (nl) 2010-04-19
AR041826A1 (es) 2005-06-01
RU2005112202A (ru) 2005-11-20
PA8586301A1 (es) 2004-05-07
RU2292207C2 (ru) 2007-01-27
US20040146562A1 (en) 2004-07-29

Similar Documents

Publication Publication Date Title
NO20051187L (no) Depotformuleringer bestaende av aktive arylheterocykliske forbindelser i form av en suspensjon
NZ542138A (en) Heterobifunctional polymeric bioconjugates
EA200701065A1 (ru) Инъецируемые составы, содержащие нанодисперсный оланзапин
CA2492096A1 (en) Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives serving as pesticides
GEP20084367B (en) Diazepinoindole derivatives as kinase inhibitors
EA200501928A1 (ru) Пирролодигидроизохинолины как ингибиторы pde10
NO20072515L (no) 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav
DK1268471T3 (da) N-heterocykliske derivater som NOS-inhibitorer
WO2004014388A8 (en) 6,6-fused heteroaryl derivatives as matrix metalloproteinase inhibitors
ATE484508T1 (de) Furylverbindungen
CY1107028T1 (el) Παραγωγα ινδανυλ-πιπεραζινων μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν
NO20054787L (no) Indenderivater som farmasotiske midler
WO2005028474A3 (en) Pyrazoloquinoline derivatives as chk-1 inhibitors
WO2004112771A8 (en) Pharmaceutical compositions including an antihistamine and a stimulant and use thereof
IL173810A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
CY1106376T1 (el) Δικυκλικα παραγωγα των αμινο-πυραζινονων, μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα πepιεχουν
UY28148A1 (es) Bromhidrato de escitalopram y un metodo para su preparacion
WO2004062562A3 (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
WO2005061496A8 (en) Aminopyridine-derivatives as inductible no-synthase inhibitors
NO20063293L (no) Farmasoytiske forbindelser
TW200509794A (en) Novel anthelmintic and insecticidal compositions
IL173809A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
IL173895A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
YU69503A (sh) Kombinacija taksana i ciklin-zavisne kinaze

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application